Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: VBB84DF6BA53EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug in Global, including the following market information:

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

SGD-2083 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug include AstraZeneca Plc, Bristol-Myers Squibb Company, Gilead Sciences Inc, Modus Therapeutics Holding AB, Novartis AG, NuvOx Pharma LLC, Pfizer Inc and Seattle Genetics Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Segment Percentages, by Type, 2021 (%)

• SGD-2083
• Crizanlizumab
• PF-04447943
• NVX-508
• Others

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Others

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca Plc
• Bristol-Myers Squibb Company
• Gilead Sciences Inc
• Modus Therapeutics Holding AB
• Novartis AG
• NuvOx Pharma LLC
• Pfizer Inc
• Seattle Genetics Inc

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VASO-OCCLUSIVE CRISIS ASSOCIATED WITH SICKLE CELL DISEASE DRUG OVERALL MARKET SIZE

2.1 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size: 2021 VS 2028
2.2 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players in Global Market
3.2 Top Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Companies Ranked by Revenue
3.3 Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue by Companies
3.4 Top 3 and Top 5 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players in Global Market
  3.6.1 List of Global Tier 1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size Markets, 2021 & 2028
  4.1.2 SGD-2083
  4.1.3 Crizanlizumab
  4.1.4 PF-04447943
  4.1.5 NVX-508
  4.1.6 Others
4.2 By Type - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue & Forecasts
  4.2.1 By Type - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2017-2022
  4.2.2 By Type - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2023-2028
  4.2.3 By Type - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue & Forecasts
  5.2.1 By Application - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2017-2022
  5.2.2 By Application - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2023-2028
  5.2.3 By Application - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2021 & 2028
6.2 By Region - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue & Forecasts
  6.2.1 By Region - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2017-2022
  6.2.2 By Region - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2023-2028
  6.2.3 By Region - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2017-2028
  6.3.2 US Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.3.3 Canada Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.3.4 Mexico Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2017-2028
  6.4.2 Germany Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.4.3 France Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.4.4 U.K. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.4.5 Italy Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.4.6 Russia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.4.8 Benelux Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2017-2028
  6.5.2 China Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.5.3 Japan Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.5.4 South Korea Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.5.6 India Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2017-2028
  6.6.2 Brazil Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.6.3 Argentina Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2017-2028
  6.7.2 Turkey Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.7.3 Israel Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028
  6.7.5 UAE Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca Plc
  7.1.1 AstraZeneca Plc Corporate Summary
  7.1.2 AstraZeneca Plc Business Overview
  7.1.3 AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Major Product Offerings
  7.1.4 AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Plc Key News
7.2 Bristol-Myers Squibb Company
  7.2.1 Bristol-Myers Squibb Company Corporate Summary
  7.2.2 Bristol-Myers Squibb Company Business Overview
  7.2.3 Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Major Product Offerings
  7.2.4 Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Company Key News
7.3 Gilead Sciences Inc
  7.3.1 Gilead Sciences Inc Corporate Summary
  7.3.2 Gilead Sciences Inc Business Overview
  7.3.3 Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Major Product Offerings
  7.3.4 Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global Market (2017-2022)
  7.3.5 Gilead Sciences Inc Key News
7.4 Modus Therapeutics Holding AB
  7.4.1 Modus Therapeutics Holding AB Corporate Summary
  7.4.2 Modus Therapeutics Holding AB Business Overview
  7.4.3 Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Major Product Offerings
  7.4.4 Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global Market (2017-2022)
  7.4.5 Modus Therapeutics Holding AB Key News
7.5 Novartis AG
  7.5.1 Novartis AG Corporate Summary
  7.5.2 Novartis AG Business Overview
  7.5.3 Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Major Product Offerings
  7.5.4 Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global Market (2017-2022)
  7.5.5 Novartis AG Key News
7.6 NuvOx Pharma LLC
  7.6.1 NuvOx Pharma LLC Corporate Summary
  7.6.2 NuvOx Pharma LLC Business Overview
  7.6.3 NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Major Product Offerings
  7.6.4 NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global Market (2017-2022)
  7.6.5 NuvOx Pharma LLC Key News
7.7 Pfizer Inc
  7.7.1 Pfizer Inc Corporate Summary
  7.7.2 Pfizer Inc Business Overview
  7.7.3 Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Major Product Offerings
  7.7.4 Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Inc Key News
7.8 Seattle Genetics Inc
  7.8.1 Seattle Genetics Inc Corporate Summary
  7.8.2 Seattle Genetics Inc Business Overview
  7.8.3 Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Major Product Offerings
  7.8.4 Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global Market (2017-2022)
  7.8.5 Seattle Genetics Inc Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Opportunities & Trends in Global Market
Table 2. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Drivers in Global Market
Table 3. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Restraints in Global Market
Table 4. Key Players of Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug in Global Market
Table 5. Top Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Type
Table 9. List of Global Tier 1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Plc Corporate Summary
Table 31. AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Offerings
Table 32. AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Company Corporate Summary
Table 34. Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Offerings
Table 35. Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences Inc Corporate Summary
Table 37. Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Offerings
Table 38. Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), (2017-2022)
Table 39. Modus Therapeutics Holding AB Corporate Summary
Table 40. Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Offerings
Table 41. Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), (2017-2022)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Offerings
Table 44. Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), (2017-2022)
Table 45. NuvOx Pharma LLC Corporate Summary
Table 46. NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Offerings
Table 47. NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Inc Corporate Summary
Table 49. Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Offerings
Table 50. Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), (2017-2022)
Table 51. Seattle Genetics Inc Corporate Summary
Table 52. Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Product Offerings
Table 53. Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Segment by Type in 2021
Figure 2. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Segment by Application in 2021
Figure 3. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue in 2021
Figure 8. By Type - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 12. US Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 16. Germany Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 24. China Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Plc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Company Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Modus Therapeutics Holding AB Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis AG Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. NuvOx Pharma LLC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Seattle Genetics Inc Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)